This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Moris G, Carcia-Monco JC . The challenge of drug-induced aseptic meningitis Arch Intern Med 1999 159: 1185–1194
Flasshove M, Schütte HJ, Kellner R, Höffken, Seeber S . Meningeal fluid granulocytosis after cytarabine Eur J Cancer 1992 28: 243
Thordarson H, Talstad I . Acute meningitis and cerebellar dysfuncion complicating high-dose cytosine arabinoside therapy Acta Med Scand 1986 220: 493–495
Wolff L, Zighelboim J, Gale RP . Paraplegia following intrathecal cytosine arabinoside Cancer 1979 43: 83–85
Patte C, Michon J, Frappaz D, Leverger G, Rubie H, Soussain C, Pico JL . Therapy of Burkitt and other B-cell acute lymphoblastic leukaemia and lymphoma: experience with the LMB protocols of the SFOP (French Paediatric Oncology Society) in children and adults Baillières Clin Haematol 1994 7: 339–348
Herzig RH, Herzig GP, Wolff SN, Hines JD, Fay JW, Phillips GL . Central nervous system effects of high-dose cytosine arabinoside Semin Oncol 1987 14: (Suppl. 1) 21–24
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van den Berg, H., van der Flier, M. & van de Wetering, M. Cytarabine-induced aseptic meningitis. Leukemia 15, 697–699 (2001). https://doi.org/10.1038/sj.leu.2402063
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402063
This article is cited by
-
Neurotoxicity of chemotherapeutic and biologic agents in children with cancer
Current Neurology and Neuroscience Reports (2008)
-
Nebenwirkungen der Therapie von Hirntumoren
Der Onkologe (2006)